Hydrofarm Holdings Group, Inc. filed a Form 8-K with the SEC on October 27, 2026, announcing the pricing of a registered direct offering and a concurrent private placement of common stock, pre-funded warrants, and common stock purchase warrants, alongside the planned termination of its $109 million senior secured term loan.

Key Highlights

  • Registered Direct Offering: Hydrofarm priced a registered direct offering of common stock under a Form S-3 registration statement (File No. 333-291444) declared effective December 10, 2025.
  • Concurrent Private Placement: The company also announced a concurrent private placement of common shares, Common Warrants, and Pre-Funded Warrants, made in reliance on Section 4(a)(2) of the Securities Act or Rule 506 of Regulation D.
  • Term Loan Termination: In connection with the offering, the company disclosed the planned termination of its $109 million senior secured term loan.
  • Term Loan Settlement: The term loan is to be satisfied and discharged through the issuance of Series 1 Non-Voting Convertible Preferred Stock and Lender Warrants to purchase common stock to the holders of the term loan, with release of related liens.
  • Stockholder Approval Required: The company disclosed that stockholder approval will be required for the conversion of the Series 1 Non-Voting Convertible Preferred Stock and the issuance of shares upon exercise of the Lender Warrants.
  • Resale Registration Commitment: Hydrofarm agreed to file a registration statement covering the resale of securities issued in the private placement, including shares underlying the Pre-Funded Warrants and Common Warrants.
  • Nasdaq Listing Risk Noted: The filing identified as a risk factor the possibility that the company may not "regain or maintain compliance with The Nasdaq Stock Market continued listing requirements."

Hydrofarm's Offering Structure and Term Loan Discharge Plan

According to the filing, Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM), a Delaware-incorporated company headquartered in Shoemakersville, Pennsylvania, announced on October 27, 2026 the pricing of a two-part capital transaction. The registered direct offering is being conducted under a previously filed Form S-3 registration statement, with the base prospectus dated December 10, 2025 and a prospectus supplement to be filed separately. ThinkEquity, located at 17 State Street, 41st Floor, New York, New York 10004, is named in the filing as the source from which copies of the final prospectus may be obtained.

The concurrent private placement is structured to rely on an exemption from Securities Act registration requirements. The filing states that the securities offered in the private placement "have not been registered under the Securities Act, or state securities laws and may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from such registration requirements." Hydrofarm, which operates in the controlled-environment agriculture supply sector, distributes horticultural equipment and supplies to commercial and home growers. The company's capital structure transaction is intended to address its existing debt obligations through a non-cash settlement mechanism involving preferred stock and warrants.

The filing contains forward-looking statements, which the company attributed to "management's current expectations and assumptions" and cautioned are "subject to risks and uncertainties that could cause actual results to differ materially." Identified risks include the possibility that the offering does not close, that conditions to term loan termination are not met, and that existing stockholders face dilution from the issuance of common stock, Pre-Funded Warrants, Common Warrants, Lender Warrants, and Series 1 Non-Voting Convertible Preferred Stock, as well as from any later conversion or exercise. The 8-K was signed by William Toler, Chief Executive Officer and Chairman of the Board of Directors.

What Was Disclosed

Hydrofarm Holdings Group filed an 8-K on October 27, 2026 disclosing the pricing of a registered direct offering and private placement of equity securities, along with a plan to terminate its $109 million senior secured term loan through issuance of Series 1 Non-Voting Convertible Preferred Stock and Lender Warrants. Attached exhibits include a press release and an investor presentation, both dated October 27, 2026.